Thank you Thank you for submitting your request, a member of our team will be in contact shortly.Cambridge Cognition Team You might also be interested: Insights 14 March 2025 SIRS 2025 | Posters & Presentations Insights 11 March 2025 AD/PD 2025 | Posters & Presentations Insights 11 March 2025 Actigraphy and wearable sensor technologies to enhance assessment in health conditions Insights 06 March 2025 CANTAB® demonstrates substantial value in one of the largest brain health studies ever conducted Insights 25 February 2025 Monument Therapeutics secures £850k to advance breakthrough schizophrenia treatment Insights 19 February 2025 Cambridge Cognition submits FDA Letter of Intent for Cognitive Impairment Assessments in Schizophrenia
